As Mig6 was shown to be a target of miR-148a-3p [19], the current study set out to investigate the regulatory mechanism of exosomal miR-148a-3p in tumor angiogenesis and glioma progression, which will highlight the further clinical therapeutic strategies to treat glioma. The gene discussed is ERRFI1; the disease is glioma.